Avenue Therapeutics, Inc. (ATXI): Price and Financial Metrics

Avenue Therapeutics, Inc. (ATXI): $3.36

0.06 (-1.75%)

POWR Rating

Component Grades








ATXI Price/Volume Stats

Current price $3.36 52-week high $93.75
Prev. close $3.42 52-week low $3.25
Day low $3.36 Volume 20,600
Day high $3.70 Avg. volume 69,106
50-day MA $5.17 Dividend yield N/A
200-day MA $17.59 Market Cap 3.16M

ATXI Stock Price Chart Interactive Chart >

Avenue Therapeutics, Inc. (ATXI) Company Bio

Avenue Therapeutics, Inc., a specialty pharmaceutical company, acquires, licenses, develops, and commercializes an intravenous formulation of tramadol HCI principally for use in the acute/intensive care hospital setting. Its product candidate is IV Tramadol for the treatment of post-operative pain. The company was founded in 2015 and is based in New York, New York.

ATXI Latest News Stream

Event/Time News Detail
Loading, please wait...

ATXI Latest Social Stream

Loading social stream, please wait...

View Full ATXI Social Stream

Latest ATXI News From Around the Web

Below are the latest news stories about AVENUE THERAPEUTICS INC that investors may wish to consider to help them evaluate ATXI as an investment opportunity.

Avenue Therapeutics to Present at American Epilepsy Society 2023 Annual Meeting

MIAMI, Dec. 01, 2023 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (Nasdaq: ATXI) (“Avenue” or the “Company”), a specialty pharmaceutical company focused on the development and commercialization of therapies for the treatment of neurologic diseases, today announced that Amy Chappell, M.D., FAAN, will be presenting preclinical in vivo data evaluating BAER-101 using the SynapCell's Genetic Absence Epilepsy Rat from Strasbourg (“GAERS”) model of absence epilepsy at the American Epilepsy Society (AE

Yahoo | December 1, 2023

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

It's time for a breakdown of the biggest pre-market stock movers as we check out all of the hottest news on Thursday morning!

William White on InvestorPlace | November 30, 2023

Why Is Avenue Therapeutics (ATXI) Stock Up 59% Today?

Avenue Therapeutics stock is rising higher on Wednesday following news of an investor taking a 14.5% stake in ATXI shares.

William White on InvestorPlace | November 29, 2023

Why Is Leslie’s (LESL) Stock Down 24% Today?

Leslie's stock is falling hard on Wednesday as investors in LESL react to it missing EPS estimates in Q4 and posting weak 2024 guidance.

William White on InvestorPlace | November 29, 2023

Why Is Seelos Therapeutics (SEEL) Stock Down 42% Today?

Seelos Therapeutics stock is falling on Wednesday after the company announced and priced a public offering for shares of SEEL.

William White on InvestorPlace | November 29, 2023

Read More 'ATXI' Stories Here

ATXI Price Returns

1-mo -7.18%
3-mo -70.33%
6-mo -72.50%
1-year -96.04%
3-year -99.88%
5-year -99.95%
YTD -72.17%
2023 -86.12%
2022 -91.48%
2021 -84.74%
2020 -38.02%
2019 77.78%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!